Add BrightSurf on Google Email

Switch to dry powder inhaler more than halves carbon footprint of asthma treatment

A study found that switching from a metered dose inhaler to a dry powder version for maintenance therapy reduces the carbon footprint of people with asthma by more than half. The researchers conclude that this substitution is an acceptable and worthwhile option for most patients who can safely manage their condition at home.

SourceBMJ Group·JournalThorax·TypeRandomized controlled/clinical trial·DateFeb 3, 2022

How LPS prevents or promotes development of asthma and allergic disease by airborne allergens

A study published in Cell Reports reveals that LPS protects against developing asthma when combined with allergens containing cysteine protease enzymatic activity, but promotes development when paired with allergens lacking this enzyme. This protective effect relies on the production of GM-CSF by non-classical monocytes.

SourceUniversity of Alabama at Birmingham·JournalCell Reports·TypeExperimental study·DateJan 5, 2022

The Lancet Planetary Health: 1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests

A recent study published in The Lancet Planetary Health found that approximately 2.5 billion people worldwide lived in areas exceeding the WHO guideline for annual average PM2.5 exposure, resulting in an excess of 1.8 million deaths. Additionally, nearly 2 million asthma cases among children were attributable to NO2 pollution in 2019.

SourceThe Lancet·JournalThe Lancet Planetary Health·TypeComputational simulation/modeling·DateJan 5, 2022

New research may identify infants who face high asthma risk after viral lung infections

Researchers found that the risk of developing asthma in infants depends on a complex interplay among the infecting virus, airway microbial composition and function, and the infant's immune response. Infants with distinct metatranscriptome profiles had unique risks of developing asthma by age five.

SourceMassachusetts General Hospital·JournalEuropean Respiratory Journal·TypeObservational study·DateDec 16, 2021

Asthma may reduce risk of brain tumors -- but how?

Researchers found that asthma causes immune cells to behave in a way that prevents brain tumor growth, suggesting a potential new therapeutic approach. The findings suggest reprogramming T cells to act like those in asthma patients could be a new treatment for brain tumors.

SourceWashU Medicine·JournalNature Communications·TypeExperimental study·DateDec 10, 2021

‘Super trees’ may help save Houston … and beyond

A new study ranks live oaks and American sycamores as champions among 17 "super trees" that can mitigate air pollution and climate change in urban areas. The research provides a three-part framework for selecting suitable trees, identifying high-impact planting sites, and engaging with community leadership to make the project a reality.

SourceRice University·JournalPlants People Planet·TypeData/statistical analysis·DateDec 9, 2021

Allergic conditions linked to lower COVID-19 infection risk

A large UK study found that individuals with atopic diseases like eczema or hay fever had a 23% lower risk of developing COVID-19. In contrast, people of Asian/Asian British ethnicity and those in crowded households faced a higher risk. The study suggests that some risk factors for severe disease may differ from those for infection.

SourceBMJ Group·JournalThorax·TypeObservational study·DateNov 30, 2021

The Lancet Respiratory Medicine: Children with poorly controlled asthma at higher risk of COVID-19 hospitalization and should be prioritized for vaccination

A national analysis found that children with poorly controlled asthma are more likely to require hospitalisation than those with well-controlled asthma or without asthma. Vaccinating this group can reduce the risk of COVID-19 infection and associated illness.

SourceThe Lancet·JournalThe Lancet Respiratory Medicine·TypeObservational study·DateNov 30, 2021

Biased beta-agonists may provide better control of asthma and other obstructive lung diseases, drug discovery study shows

A University of South Florida Health-led team discovered a lead candidate that selectively relaxes airway smooth muscle cells with no detectable drug desensitization. The biased beta-agonist, C1-S, offers a therapeutic option for asthma and obstructive lung diseases without the rapid loss of effectiveness seen with traditional β-agonists.

SourceUniversity of South Florida (USF Health)·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateNov 22, 2021

High consumption of cow’s milk associated with higher risk of developing preclinical type 1 diabetes in genetically predisposed children

A study by Katariina Koivusaari found that high cow's milk consumption is associated with a higher risk of developing preclinical type 1 diabetes in genetically predisposed children. The study also linked high-temperature treated infant formula to an increased risk of asthma in children.

SourceUniversity of Helsinki·JournalPediatric Allergy and Immunology·DateNov 18, 2021

New clinical practice guideline on fractional exhaled nitric oxide (FeNO) to help guide asthma treatment

The American Thoracic Society has published a clinical practice guideline on the use of fractional exhaled nitric oxide (FeNO) to guide asthma treatment. The guideline recommends using FeNO in addition to usual care for patients with asthma whose treatment is being considered, suggesting this may be eligible for the measurement.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·TypeSystematic review·DateNov 17, 2021

Most young people with asthma haven’t been prepared to transition to adult asthma care

A new study reveals that many young adults with asthma are not prepared to transition to adult asthma care. The survey found that half of all respondents did not receive sufficient transition preparation from their pediatric providers, highlighting the need for better education and support.

SourceAmerican College of Allergy, Asthma, and Immunology·JournalAnnals of Allergy Asthma & Immunology·TypeSurvey·DateNov 5, 2021

D​​​​espite climate change, kids with asthma in Los Angeles didn’t have an increase in allergy diagnoses

A new study followed 5,000 kids with asthma in Los Angeles for 15 years and found no significant increase in allergic sensitizations to environmental allergens. Despite rising temperatures and pollen loads, children with asthma were not more likely to become sensitized to specific pollens.

SourceAmerican College of Allergy, Asthma, and Immunology·JournalAnnals of Allergy Asthma & Immunology·TypeObservational study·DateNov 5, 2021

Childhood asthma study uncovers risky air pollutant mixtures

Researchers developed a novel machine learning algorithm to identify previously unknown air pollutant mixtures linked to poor asthma outcomes in children. The study found that early exposure to individual and mixed pollutants can lead to longer-term problems with asthma, affecting about seven percent of US children.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalJournal of Clinical Investigation·TypeData/statistical analysis·DateOct 7, 2021

Study explores why asthma worsens at night

Researchers investigate how the internal circadian clock affects asthma severity. The study found that people with worse asthma experience greater drops in pulmonary function at night, and exhibit more symptoms-driven bronchodilator use during nighttime hours. This understanding could lead to new treatments for asthma.

SourceBrigham and Women's Hospital·JournalProceedings of the National Academy of Sciences·DateSep 6, 2021

Bisexual adults more than twice as likely to have asthma as straight adults

A new national study published in Annals of the American Thoracic Society found that bisexual Americans had over two times the rates of asthma and other lung diseases compared to heterosexual adults. Higher levels of discrimination experienced by bisexual people may lead to increased stress, inflammation, and worsened asthma.

SourceUniversity of Toronto·JournalAnnals of the American Thoracic Society·TypeData/statistical analysis·DateSep 3, 2021

To avoid severe COVID-19 outcomes, people with asthma should stay on top of the condition with control medication during the pandemic

Researchers found individuals with well-controlled asthma have significantly lower odds of hospitalization and ICU admission compared to those with uncontrolled asthma. Asthma patients using their medications showed a decrease in worsened COVID-19 outcomes.

SourceKeck School of Medicine of USC·JournalThe Journal of Allergy and Clinical Immunology In Practice·TypeData/statistical analysis·DateAug 10, 2021